Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Galapagos N.V.

GLPG
Current price
25.54 EUR -0.7 EUR (-2.67%)
Last closed 26.38 EUR
ISIN BE0003818359
Sector Healthcare
Industry Biotechnology
Exchange Euronext Amsterdam
Capitalization 1 776 970 079 EUR
Yield for 12 month -25.50 %
1Y
3Y
5Y
10Y
15Y
GLPG
21.11.2021 - 28.11.2021

Galapagos NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667 that has completed phase 1b trial; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in Phase1/2 trial in relapsed/refractory non-hodgkin lymphoma; GLPG5201, a CD19 CAR-T product candidates manufactured at point-of-care, currently in phase 1/2 trial in replapsed/refractory chronic lymphocytic leukemia; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc.; and AbbVie S.à r.l. Galapagos NV was incorporated in 1999 and is headquartered in Mechelen, Belgium. Address: Generaal De Wittelaan L11 A3, Mechelen, Belgium, 2800

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

34.62 EUR

P/E ratio

Dividend Yield

Current Year

+242 279 496 EUR

Last Year

+510 717 496 EUR

Current Quarter

+78 711 019 EUR

Last Quarter

+63 103 853 EUR

Current Year

+205 903 206 EUR

Last Year

+498 508 510 EUR

Current Quarter

+61 975 843 EUR

Last Quarter

+60 528 433 EUR

Key Figures GLPG

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -137 498 670 EUR
Operating Margin TTM -90.74 %
PE Ratio
Return On Assets TTM -2.38 %
PEG Ratio
Return On Equity TTM -2.21 %
Wall Street Target Price 34.62 EUR
Revenue TTM 262 892 963 EUR
Book Value 43.88 EUR
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -50.1 %
Dividend Yield
Gross Profit TTM 4 869 848 EUR
Earnings per share -0.93 EUR
Diluted Eps TTM -0.93 EUR
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY 74.8 %
Profit Margin 79.33 %

Dividend Analytics GLPG

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History GLPG

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation GLPG

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 166.6667
Enterprise Value Revenue 0.9891
Price Sales TTM 6.7593
Enterprise Value EBITDA -29.4775
Price Book MRQ 0.5783

Financials GLPG

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators GLPG

For 52 weeks

22.24 EUR 39.42 EUR
50 Day MA 26.68 EUR
Shares Short Prior Month
200 Day MA 27.56 EUR
Short Ratio
Shares Short
Short Percent